JNJ-38518168 (30 mg)

DRUG2 trials

Sponsors

Janssen Research & Development, LLC

Conditions

Healthy Male VolunteerRheumatoid Arthritis

Phase 1

A Study of the Safety and Pharmacokinetics of JNJ-38518168 in Japanese and Caucasian Male Participants and the Effect of JNJ-38518168 on the Blood Levels of Midazolam

CompletedNCT01442532

Janssen Research & Development, LLCHealthy Male Volunteer

Start: 2011-09-30End: 2012-07-31Updated: 2013-03-04

Phase 2

A Dose Range Finding Study of JNJ-38518168 in Patients With Active Rheumatoid Arthritis in Spite of Treatment With Methotrexate

TerminatedNCT01679951

Janssen Research & Development, LLCRheumatoid Arthritis

Start: 2012-10-31End: 2014-07-03Updated: 2019-03-18